OKYO Pharma Ltd
OKYO- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001849296
In the last 90 days, OKYO Pharma Ltd insiders filed 7 open-market purchases and 0 sales; 19 institutions reported holding it in 13F filings for Q2 2026, worth $9.74M in total; no superinvestor holds it.
13F holders, Q4 2024
Institutional positions in OKYO Pharma Ltd as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 7
- +1 vs. Q3 2024
- Shares held
- 1.03M
- +24.8K (+2.5%) vs. Q3 2024
- Total value
- $1.18M
- +$158.4K (+15.5%) vs. Q3 2024
- New holders
- 1
- 2 more added
- Sold out
- 0
- 0 more reduced
Compare with Q3 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting OKYO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 19 | $9.74M |
| Q1 2026 | 12 | $10.3M |
| Q4 2025 | 10 | $1.15M |
| Q3 2025 | 8 | $5.14M |
| Q2 2025 | 5 | $1.48M |
| Q1 2025 | 7 | $2.63M |
| Q4 2024 | 7 | $1.18M |
| Q3 2024 | 6 | $1.02M |
| Q2 2024 | 7 | $1.21M |
| Q1 2024 | 6 | $1.36M |
| Q4 2023 | 7 | $1.51M |
| Q3 2023 | 7 | $176.0K |
| Q2 2023 | 2 | $14.1K |
| Q1 2023 | 1 | $33.3K |
| Q4 2022 | 1 | $14.4K |
| Q3 2022 | 1 | $3.00K |
| Q2 2022 | 3 | $62.0K |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2024
Shares, value and share of portfolio for each institution holding OKYO Pharma Ltd; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Barclays PLC | 961,000 | $1.11M | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 20,729 | $23.8K | 0.00% | +5,853+39.3% | Added |
| Renaissance Technologies LLC | 16,500 | $19.0K | 0.00% | +16,500 | New |
| Cerity Partners LLC | 12,812 | $14.7K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 12,090 | $13.9K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 2,998 | $3.45K | 0.00% | +2,473+471.0% | Added |
| Continuum Advisory, LLC | 50 | $58 | 0.00% | 00.0% | Unchanged |